The Scripps Research Institute - 2/8

Entry	Author	Date	Location
Novartis-backed Genomics Institute Names Martin Seidel as New Director, Replacing Peter Schultz	Luke Timmerman	10/05/10	San Diego
NextBio Finds Profit at Intersection Between Public and Private Genomic Data	Luke Timmerman	09/28/10	San Francisco
Genomics in San Diego: From the Human Genome to a New Biotechnology Focus	Mary Canady	08/13/10	San Diego
Allozyne Inks Sigma-Aldrich Deal	Luke Timmerman	08/12/10	Seattle
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics	Luke Timmerman	07/19/10	San Francisco
Kristina Burow, Arch’s Rising Star in SF, Spots Big Ideas in Biotech, Cleantech	Luke Timmerman	07/16/10	San Francisco
Allozyne Licenses Scripps Chemistry	Luke Timmerman	07/14/10	Seattle
Peter Schultz Exits Top Job at Genomics Institute of the Novartis Research Foundation	Luke Timmerman	07/14/10	San Diego
Ambrx CEO Steve Kaldor Departs	Luke Timmerman	07/12/10	San Diego
Theraclone Sciences CEO David Fanning Dies Suddenly	Luke Timmerman	06/14/10	Seattle
Mendlein Joins aTyr as Chairman	Luke Timmerman	05/26/10	San Diego
Alder’s Long-Awaited Arthritis Data, Ikaria Plots $200M IPO, Emerald’s Resurrection, & More Seattle-Area Life Sciences News	Luke Timmerman	05/20/10	Seattle
Scripps Chemistry Idea “Clicks” With Big Pharma, Seattle’s Integrated Diagnostics	Luke Timmerman	05/19/10	San Diego
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s	Luke Timmerman	05/03/10	Boston
Fate Therapeutics Expands its Stem Cell Empire Into Canada	Luke Timmerman	04/08/10	National
The Great iPad Debate Begins, Hookit Taps Growing Market, Four Under the Radar Deals, & More San Diego BizTech News	Luke Timmerman	04/05/10	San Diego
San Diego Biotech in 2030: A Center for Stem Cells, Genomics, Software, Neuroscience	Luke Timmerman	04/02/10	San Diego
The 20-Year Outlook for San Diego Life Sciences: Sold Out? Not Anymore	Luke Timmerman	03/15/10	San Diego
The 20-Year Future of San Diego Biotech, Coming March 31	Luke Timmerman	03/09/10	San Diego
Scientists from Sapphire Energy, UCSD, Scripps, and Protelica Show Genetically Modified Algae Can Make Important Drugs	Bruce V. Bigelow	03/08/10	San Diego
ActivX Biosciences, Showing Life After Takeover, Keeps Innovative Ties in San Diego	Luke Timmerman	03/04/10	San Diego
Proteostasis, a Rich Boston Biotech with San Diego Ties, Grows to Pursue Diseases of Aging	Luke Timmerman	02/18/10	Boston
What Will San Diego’s Biotech Hub Look Like in 20 Years? Xconomy Event Takes Long View	Luke Timmerman	02/16/10	San Diego
Burnham Snags $50M Gift, Sparks Translation of Basic Science into New Treatments	Luke Timmerman	01/26/10	San Diego
Zogenix Raises Cash for Headaches, Sleepless in Somaxon, Dow Chemical Spins Out Pfēnex, & More San Diego Life Sciences News	Bruce V. Bigelow	12/10/09	San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday	Luke Timmerman	12/09/09	San Diego
Scripps’ Young Tech Transfer Boss Seeks to Cut Deals With Industry, Not Just Push Paper	Luke Timmerman	12/03/09	San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology	Luke Timmerman	12/01/09	San Diego
Receptos, Led By Biogen Idec Vets and Scripps Stars, Snags $25M For Drug Discovery Engine	Luke Timmerman	11/23/09	San Diego
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells	Luke Timmerman	11/16/09	National
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

Novartis-backed Genomics Institute Names Martin Seidel as New Director, Replacing Peter Schultz

Luke Timmerman

10/05/10

San Diego

NextBio Finds Profit at Intersection Between Public and Private Genomic Data

Luke Timmerman

09/28/10

San Francisco